ClinicalTrials.gov · NCT04946383 · Unknown status
Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging
Registry record
NCT04946383 on ClinicalTrials.gov. The registry's last update to this record was 3 August 2021.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor TruDiagnostic Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Dasatinib plus Quercetin Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Epigenetic Age Test Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Unknown status Checked Source clinicaltrials.gov Overall status as registered; registry last update 2021-08-03. Checked
Check history: NCT04946383 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: TruDiagnostic
- Phase: Phase 2
- Status: Unknown status
- Intervention: Dasatinib plus Quercetin
- Primary outcome: Epigenetic Age Test
- Countries: United States
- Start: 16 December 2020
- Completion (estimated): 30 June 2022
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.
Related modality